Literature DB >> 35223130

Prevalence and associated factors of depression, anxiety and stress among coronavirus disease 2019 (COVID-19) patients in Herat, Afghanistan.

Aziz-Ur-Rahman Niazi1, Mina Alekozay1, Abdul Fattah Najm2.   

Abstract

Objectives: Coronavirus disease 2019 (COVID-19) pandemic has been associated with a great level of psychological distresses in people around the world. This study aims to assess the prevalence of depression, anxiety and stress among COVID-19 patients and identify the associated factors, in Herat Province of Afghanistan.
Methods: This cross-sectional study was conducted on 459 hospitalized patients between May and September 2021. Data was collected with a structured questionnaire on depression, anxiety and stress scale, which was the validated Dari-version. Chi-square test was adopted to analyze the associations of the prevalence of the mental disorders and the factors.
Results: The mean age of participants was 38.05; 51.9% (238/459) were male and 84.1% (386/459) were married. Median scores for depression, anxiety and stress were 5.0, 8.0, and 10.0, respectively. Gender, general health condition, nutritional status, COVID-19 clinical manifestation and concurrent comorbidities (except diabetes and hypertension) were significantly associated with mental disorders; while association between marital status and these psychological disorders was not significant. Moreover, a significant difference was observed in the level of anxiety between healthcare workers and other respondents.
Conclusion: This is the first study to report the high prevalence of depression, anxiety and stress among COVID-19 patients in Herat, which indicates the negative effect of mental health for COVID-19 patients globally and highlights the need for urgent and appropriate interventions to improve mental health of people during the pandemic.
Copyright © 2022 People's Medical Publishing House Co. Ltd. Publishing service by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.

Entities:  

Keywords:  Afghanistan; Anxiety; Coronavirus disease 2019 (COVID-19); Depression; Herat; Stress

Year:  2022        PMID: 35223130      PMCID: PMC8863950          DOI: 10.1016/j.glohj.2022.02.001

Source DB:  PubMed          Journal:  Glob Health J        ISSN: 2414-6447


Introduction

The coronavirus disease 2019 (COVID-19) was first reported in Wuhan City of China at the end of 2019. On 11 March 2020, the disease which is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was characterized as “pandemic” by the World Health Organization (WHO). In Afghanistan, the first case of COVID-19 was diagnosed on 24 February 2020, in Herat Province (hereafter referred as Herat). , The pandemic rapidly spreads in the world, affecting more people day by day. As of 1 February 2022, over 360 million COVID-19 cases and 5.6 million deaths have been confirmed in the world, of which over 160 000 cases and 7 400 deaths come from Afghanistan. Due to the rapid spread and negative impacts on economy, health and well-being of people, many studies assessed the impact of COVID-19 pandemic on psychological status of the patients, mainly including impulsivity, insomnia, cognitive impairment, persistent fatigue and mood disorders.6, 7, 8, 9, 10 Accumulating evidence suggests that COVID-19 can cause many mental illnesses such as depression, anxiety, stress and suicidal behavior.9, 10, 11, 12, 13, 14 This highlighted the need for a thorough understanding of the magnitude of these mental illnesses during the pandemic. Several studies have assessed the prevalence of depression, anxiety and stress among COVID-19 patients. These studies reported the prevalence of depression to be about (22.6%‒64.7%), anxiety (16.4%‒51.6%) and stress (17.8%‒41.2%). , 14, 15, 16, 17, 18, 19 Additionally, these studies have also examined factors associated with mental illnesses in COVID-19 patients. Limited access to health care, having pre-existing comorbidities, general health,15, 16, 17, 18 employment and economic status,19, 20, 21 marital status, , , being female,15, 16, 17 , 19, 20 , 22, 23, 24, 25, 26, 27 and education , 28, 29 have been identified as associated factors of depression, anxiety and stress in COVID-19 patients in general population. Considering the paucity of research on assessing the prevalence and consequence on psychological status of COVID-19 patients in Afghanistan, this study aims to identify the magnitude and associated factors of these common mental illnesses among COVID-19 patients in Herat, which can serve as a baseline reference for future work in this field in the region.

Methods

Study design

This cross-sectional study recruited COVID-19 patients who from May to September 2021 attended Shahid Basim's COVID-19 Hospital in Herat. This hospital provides COVID-19 tertiary care services for Herat's residents.

Eligibility criteria and participants

The eligibility criteria were: (1) Dari-speaker; (2) living in Herat; (3) polymerase chain reaction-test was positive. A total of 459 COVID-19 patients, aged 18‒80 years, and hospitalized at Shahid Basim's COVID-19 Hospital were included in this study.

Ethical consideration

The Human Ethics Committee of Herat University approved the study protocol (Approval number #200,221). A written informed consent was obtained prior to the conduct of interview and acquisition of data. Privacy and confidentiality of information was maintained throughout the study.

Survey instrument

Sociodemographic data including patients’ gender, age, marital status, education, employment, respondents’ self-perceived economic status, general health and nutritional status, along with clinical presentations and the existence of comorbidities were collected by a psychiatrist, at Shahid Basim's COVID-19 Hospital, using a paper-based structured questionnaire. Depression, anxiety and stress scale (DASS) questionnaire was employed in this study, because it was recently used to assess psychological responses during COVID-19 pandemic in many countries, including China, Spain, the USA, Poland, Iran, the Philippines and Vietnam.31, 32, 33, 34, 35, 36 This DASS questionnaire was the validated Dari-translated version of 42-item.  Each item was rated on a 4-point severity using 0‒3 scale; with 0 implying “it did not apply to me” and 3 “it applied to me very much”. Scores for each subscale were calculated by summing the scores of all items in relevant subscale. Therefore, the highest possible scores were 42 for each depression, anxiety and stress subscales. Patients considered “normal”, when their scores were 0‒7 for depression, 0‒4 for anxiety and 0‒10 for stress, respectively.

Statistical analyses

Statistical analyses were performed with SPSS 27.0 Statistics (IBM). Continuous variables with normal distribution were presented as means ± standard deviation ( ± s). Non-normally distributed variables were shown as median and inter-quartile range (IQR). Categorical variables were presented as numbers and percentages. The association between categorical variables was assessed by Chi-square tests. The level of significance was set to P < 0.05.

Results

Socio-demographic characteristics of the participants

A total of 459 patients were included in this study, which were aged 18 to 80 (38.05 ± 13.20) years. Socio-demographic characteristics of those patients were displayed in Table 1 . About 51.9% (238/459) of the patients were male, 84.1% (386/459) were married, and 19.0% (87/459) were illiterate. Nearly 16.8% (77/459) of the participants were healthcare workers, while 12.2% (56/459) were unemployed, and 14.2% (65/459) had a weak economic status. Of all participants, 75.4% (346/459) had good health, and 55.8% (256/459) had good nutrition.
Table 1

Socio-demographic characteristics of study participants.

VariablesNumberPercentage
Gender
 Male23851.9
 Female22148.1
Age
 ≤ 35 years23451.0
 > 35 years22549.0
Education level
 Illiterate8719.0
 Primary7716.8
 School graduate6714.6
 Undergraduate19241.8
 Master degree367.8
Marital status
 Single7315.9
 Married38684.1
Employment
 Governmental employee11024.0
 Self-employed21647.1
 Healthcare worker7716.8
 Unemployed5612.2
Economic status
 Poor6514.2
 Fair34174.3
 Good5311.5
General health condition
 Weak7616.6
 Good34675.4
 Excellent378.1
Nutrition
 Weak9220.0
 Good25655.8
 Excellent11124.2
Socio-demographic characteristics of study participants.

Prevalence of depression, anxiety and stress

Of all participants in this study, 31.7% (146/459) reported moderate to extremely severe depression, 42.9% (197/459) reported moderate to extremely severe stress, and 69.7% (320/459) reported moderate to extremely severe anxiety. Of a significant interest was the high percentage (42.3%, 194/459) of extremely severe anxiety among study participants. Table 2 shows the levels of depression, anxiety and stress among study participants. The median and IQR of depression, anxiety and stress in this study were 5 (1‒12), 8 (4‒13), and 10 (5‒18), respectively.
Table 2

The prevalence of depression, anxiety and stress among study participants [n (%)].

VariableNormalMildModerateSevereExtremely severe
Depression270 (58.8)43 (9.4)57 (12.4)36 (7.8)53 (11.5)
Anxiety94 (20.5)45 (9.8)79 (17.2)47 (10.2)194 (42.3)
Stress236 (51.4)26 (5.7)80 (17.4)60 (13.1)57 (12.4)
The prevalence of depression, anxiety and stress among study participants [n (%)].

Association of socio-demographic characteristics with depression, anxiety and stress

More female participants were suffering from depression, anxiety and stress than males (P < 0.001). Also, a significant association was observed between general health condition and nutritional status with depression, anxiety and stress (all P < 0.001). No significant difference was observed between depression, anxiety and stress and marital status. Table 3 displays the association of participants’ socio-demographic characteristics with depression, anxiety and stress among study participants.
Table 3

Association of socio-demographic factors with depression, anxiety and stress among study participants [n (%)].

VariablesTotal numberDepressionAnxietyStress
Gender
 Male23870 (29.4)171 (71.8)84 (35.3)
 Female221119 (53.8)194 (87.8)139 (62.9)
P< 0.001< 0.001< 0.001
Age
 ≤ 35 years234101 (43.2)190 (81.2)124 (53.0)
 > 35 years22588 (39.1)175 (77.8)99 (44.0)
P0.3780.03640.054
Role in the family
 Father19064 ( 33.7)136  (71.6)69 (36.3)
 Mother17393 ( 53.8)154 (89.0)110 (63.6)
 Child9632 (33.3)75 (78.1)44 (45.8)
P< 0.001< 0.001< 0.001
Educational level
 Illiterate8746 (52.9)78 (89.7)51 (58.6)
 Primary7728 (36.4)63 (81.8)35 (45.5)
 School graduate6733 (49.3)56 (83.6)36 (53.7)
 Undergraduate19271 (37.0)146 (76.0)89 (46.4)
 Master degree3611 (30.6)22 (61.1)12 (33.3)
P0.0320.0040.083
Employment
 Government employee11038 (34.5)82 (74.5)46 (41.8)
 Self-employed216101 (46.8)186 (86.1)116 (53.7)
 Healthcare worker7732 (41.6)54 (70.1)42 (54.5)
 Jobless5618 (32.1)43 (76.8)19 (33.9)
P0.0830.0080.017
Marital status
 Single7327 (37.0)60 (82.2)32 (43.8)
 Married386162 (42.0)305 (79.0)191 (49.5)
P0.4280.5370.376
Economic status
 Weak6536 (55.4)55 (84.6)39 (60.0)
 Middle341135 (39.6)273 (80.1)160 (46.9)
 High5318 (34.0)37 (69.8)24 (45.3)
P0.0320.1250.135
General health condition
 Weak7650 (65.8)73 (96.1)53 (69.7)
 Good346124 (35.8)272 (78.6)154 (44.5)
 Excellent3715 (40.5)20 (54.1)16 (43.2)
P< 0.001< 0.001< 0.001
Nutritional status
 Weak9260 (65.2)88 (95.7)62 (67.4)
 Good25688 (34.4)202 (78.9)113 (44.1)
 Excellent11141 (36.9)75 (67.6)48 (43.2)
P< 0.001< 0.001< 0.001
Association of socio-demographic factors with depression, anxiety and stress among study participants [n (%)].

Association of clinical manifestations with depression, anxiety and stress

The majority of patients in this study presented with fatigue (78.2%), body-ache (73.0%), fever (70.2%), headache (69.7%), and cough (62.7%). Table 4 shows the association between clinical manifestations with depression, anxiety and stress among study participants. There were insignificant associations between fever and stress, cough and depression, and diarrhea and depression (P > 0.05). Beside, significant associations were observed between all other clinical manifestations with depression, anxiety and stress (P < 0.05).
Table 4

Association of clinical features with depression, anxiety and stress among study participants [n (%)].

Clinical featureTotal numberDepressionAnxietyStress
Fever
 Yes322147 (45.7)278 (86.3)163 (50.6)
 No13742 (30.7)87 (63.5)60 (43.8)
P0.003< 0.0010.181
Cough
 Yes288128 (44.4)251 (87.2)151 (52.4 )
 No17161 (35.7)114 (66.7)72 (42.1)
P0.065< 0.0010.032
Headache
 Yes320148 (46.3)275 (85.9)173 (54.1)
 No13941 (29.5)90 (64.7)50 (36.0)
P0.001< 0.001< 0.001
Diarrhea
 Yes15674 (47.4)136 (87.2)89 (57.1)
 No303115 (38.0)229(75.6)134 (44.2)
P0.0510.0040.009
Body-ache
 Yes335151 (45.1)287 (85.7)175 (52.2)
 No12438 (30.6)78 (62.9)48 (38.7)
P0.005< 0.0010.010
Fatigue
 Yes359160 (44.6)312 (86.9)186 (51.8)
 No10029 (29.0)53 (53.0)37 (37.0)
P0.005< 0.0010.009
Sore throat
 Yes218105 (48.2)193 (88.5)123 (56.4)
 No24184 (34.9)172 (71.4)100 (41.5)
P0.004< 0.0010.001
Dyspnea
 Yes222107 (48.2)206 (92.8)125 (56.3 )
 No23782 (34.6)159 (67.1)98 (41.4)
P0.003< 0.0010.001
Severity of features
 Mild11631 (26.7)65 (56.0)38 (32.8)
 Moderate22985 (37.1)193 (84.3)105(45.9)
 Severe11473 (64.0)107 (93.9)80 (70.2)
P< 0.001< 0.001< 0.001
Association of clinical features with depression, anxiety and stress among study participants [n (%)].

Association of comorbidities with depression, anxiety and stress

With regard to comorbidities, 24.4% (112/459) vitamin D deficiency, 13.9% (64/459) hypertension, 11.8% (54/459) kidney diseases, 9.4% (43/459) respiratory diseases, 7.0% (32/459) had diabetes, and 7.0% (32/459) cardiovascular diseases. No significant association was observed between diabetes and depression, anxiety, and stress (P > 0.05). Also, the association between hypertension and anxiety was not significant, as well with stress (P > 0.05). However, the association between hypertension and depression was significant (P < 0.05). Besides, the association between other comorbidities with depression, anxiety and stress were all significant (P < 0.05, Table 5 ).
Table 5

Association of patient's comorbidities with depression, anxiety and stress among study participants [n (%)].

Bio dataTotal numberDepressionAnxietyStress
Diabetes
 Yes3211 (34.4)27 (84.4)17 (53.1)
 No427178 (41.7)338 (79.2)206 (48.2)
P0.4180.4800.594
Hypertension
 Yes6434 (53.1)56 (87.5)34 (53.1)
 No395155 (39.2)309 (78.2)189 (47.8)
P0.0360.8880.433
Cardiovascular diseases
 Yes3219 (59.4)30 (93.8)21 (65.6)
 No427170 (39.8)335 (78.5)202 (47.3)
P0.0300.0390.046
Kidney diseases
 Yes5433 (61.1)50 (92.6)40 (74.1)
 No405156 (38.5)315 (77.8)183 (45.2)
P0.0020.011< 0.001
Respiratory diseases
 Yes4327 (62.8)41 (95.3)28 (65.1)
 No402151 (37.6)310 (77.1)185 (46.0)
 I do not know1411 (78.6)14 (100.0)10 (71.4)
P< 0.0010.0030.013
Vitamin D deficiency
 Yes11261 (54.5)95 (84.8)77 (68.8)
 No16550 (30.3)120 (72.7)58 (35.2)
 I do not know18278 (42.9)150 (82.4)88 (48.4)
P< 0.0010.023< 0.001
Association of patient's comorbidities with depression, anxiety and stress among study participants [n (%)].

Comparison of levels of depression, anxiety and stress between healthcare workers and other study participants

The chronic exposure of healthcare workers to occupational stresses may predispose them to different levels and severity of mental illnesses. Although no significant association was observed in the levels of depression and stress between healthcare workers and other participants (P > 0.05), the difference in anxiety between them was significant (P < 0.05).

Discussion

This is the first study that reported the prevalence and contributing factors of depression, anxiety and stress in general population suffering from COVID-19, in Afghanistan. The prevalence of depression, anxiety and stress in this study were 41.2% (189/459), 79.5% (365/459) and 48.6% (223/459), respectively. Our results indicate that the most prevalent mental health disorder in this study was anxiety; which is consistent with the findings of other studies from Ecuador, China, and Iran, in which anxiety was reported the most common mental health disorder among study participants. However, studies from Saudi Arabia, Turkey, and China, found that depression was the most prevalent mental disorder among study participants. Our findings indicated that female was significantly associated with higher levels of depression, anxiety and stress, which is in accordance with the findings of many other studies around the world.15, 16, 17 , , , 24, 25, 26, 27 However, it should be noted that females were also susceptible to higher levels of depression even before the pandemic. We found that educational level was not significantly associated with depression, anxiety and stress. This is similar to the findings of studies from Saudi Arabia, and China, , but is in contradiction with the results reported from Japan and Iran in which a significant association was found between educational level and mental illnesses under study. Unlike the popular belief that individuals with higher education levels may suffer from greater magnitude of psychological disorders due to their higher levels of self-awareness regarding their health, our study found that well over half the illiterate participants suffer from depression, anxiety and stress. This study also found that marital status was not significantly associated with mental illnesses. A similar finding was reported from China. , This is unlike similar studies from Saudi Arabia, Turkey, and Ecuador, that reported a significant association between marital status and depression, anxiety and stress, i.e. significantly higher rates of mental illnesses among single populations. This study also found that respondents’ employment status was significantly associated with depression and stress but not with anxiety. Higher and statistically significant number of self-employed respondents was suffering from anxiety and stress. This may be due to the fact that government employee and healthcare workers were certain that their wages would have been paid, regardless of their COVID-19 infection. Also, there was no considerable change in the income of unemployed participants before and during COVID-19 pandemic. Hence, self-employed individuals were more concerned about their income and living costs, making them susceptible to mental disorders. A similar study in Saudi Arabia reported that the employment status of the participants was associated with depression, but not with anxiety and stress. We also found that a poor health status of respondents was significantly associated with depression, anxiety and stress. This is in line with a study from Saudi Arabia which reported that poor health condition was associated with anxiety and stress, while another study from India found that chronic health condition was associated with stress. Our results indicate that economic status was associated with depression, but not with anxiety and stress. A study from China reported a significant association between household income with depression and anxiety, while another study from Japan stated that economic status was associated with all three mental illnesses under study. Another study in China reported that depression and anxiety were insignificantly associated with monthly income. We found that COVID-19 symptoms in our participants were significantly associated with depression, anxiety and stress. Similarly, a study from Japan reported that respondents with COVID-19 symptoms were significantly more prone to mental health illnesses. These indicate that being infected with COVID-19 can be an important correlate of psychological illnesses, due to its rapid progression, its consequences on health, economy and interpersonal relationship. The current study highlighted an association between the age of respondents and anxiety, but not depression and stress. This aligns with the findings of a study from Japan, which reported a significant association between age and anxiety, but not with stress and depression. This indicates that age can be a significant contributing factor for development of anxiety in COVID-19 patients.

Limitations

The current study had a few limitations. Firstly, a baseline pre-pandemic data was not available on the magnitude of depression, anxiety and stress for comparison. Therefore, we could not be certain whether there was a considerable increase in the level of these mental illnesses in study participants. Secondly, our data was collected from patients who were hospitalized at Shahid Basim's COVID-19 Hospital in Herat, not involving patients with mild illnesses under self-isolation at home. Thirdly, though COVID-19 was reported to impair the olfactory function38, 39, 40 and specific questionnaires as well a smell identification test were recently developed to assess it, , the 42-item questionnaire which we used in this study did not cover the olfactory function issues yet. Fourthly, although studies revealed that COVID-19 causes hemorrhagic changes in the brain, we only used a self-reported questionnaire to assess the magnitude and severity of depression, anxiety, and stress among participants in this study. At last, we restricted this study to Dari-speaking patients, because our instrument (DASS questionnaire) was only validated for Dari-speaking people. Therefore, COVID-19 patients with other languages were not included into this study.

Recommendation

Considering the high prevalence of depression, anxiety and stress among COVID-19 patients, accumulating evidence recommends psychological and behavioral interventions, particularly digital cognitive behavior therapy (CBT) and online psychological counselling,43, 44, 45 as adjuvant therapy to help COVID-19 patients and their families.

Conclusion

Depression, anxiety and stress are very prevalent in general COVID-19 patients in Herat. Females, those with poor health condition and poor nutritional status, those with apparent COVID-19 symptoms, and concurrent comorbidities were at higher risk of developing these mental disorders. Considering global research evidence, including this study, it seems that COVID-19 negatively affects the mental health of people around the world. Public health sectors and policy makers should pay particular attention to mental health of COVID-19 patients as well as health workers, and minimize the pandemic's impact on mental health of all populations.

Acknowledgements

The authors appreciate Dr. Aziz Ahmad JAMI, Dr. Shafiq Ahmad JOYA, Dr. Ahmad Saeed MAHMOODI, and Dr. Sayed Abo Bakar RASOOLI for their contribution to initial conceptualization of the project.

CRediT author statement

Aziz-ur-Rahman Niazi: Conceptualization, Methodology, Formal analysis, Data curation, Writing—Original draft, Writing—Reviewing & Editing, Supervision, Funding acquisition. Mina Alekozay: Conceptualization, Methodology, Data curation, Writing—Original draft, Writing—Reviewing & Editing. Abdul Fattah Najm: Conceptualization, Methodology, Formal analysis, Data curation, Writing—Original draft, Writing—Reviewing & Editing, Funding acquisition.

Ethical approval and consent to participate

The Human Ethics Committee of Herat University of Afghanistan approved the study protocol (Approval number #200,221). Written informed consents were obtained from the participants prior to this study.

Funding

This study was supported by the Department of Public Health and Infectious Diseases of the Faculty of Medicine—Herat University and the International Assistance Mission (IAM)—Herat office. This project was funded by the International Assistance Mission (Grant number #323,216).

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  40 in total

1.  Prevalence of Depression in the Community from 30 Countries between 1994 and 2014.

Authors:  Grace Y Lim; Wilson W Tam; Yanxia Lu; Cyrus S Ho; Melvyn W Zhang; Roger C Ho
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.996

2.  Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis.

Authors:  Nader Salari; Amin Hosseinian-Far; Rostam Jalali; Aliakbar Vaisi-Raygani; Shna Rasoulpoor; Masoud Mohammadi; Shabnam Rasoulpoor; Behnam Khaledi-Paveh
Journal:  Global Health       Date:  2020-07-06       Impact factor: 4.185

3.  The Psychological Experience and Intervention in Post-Acute COVID-19 Inpatients.

Authors:  Silvia Rossi Ferrario; Anna Panzeri; Paola Cerutti; Daniela Sacco
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-11       Impact factor: 2.570

4.  A chain mediation model on COVID-19 symptoms and mental health outcomes in Americans, Asians and Europeans.

Authors:  Cuiyan Wang; Agata Chudzicka-Czupała; Michael L Tee; María Inmaculada López Núñez; Connor Tripp; Mohammad A Fardin; Hina A Habib; Bach X Tran; Katarzyna Adamus; Joseph Anlacan; Marta E Aparicio García; Damian Grabowski; Shahzad Hussain; Men T Hoang; Mateusz Hetnał; Xuan T Le; Wenfang Ma; Hai Q Pham; Patrick Wincy C Reyes; Mahmoud Shirazi; Yilin Tan; Cherica A Tee; Linkang Xu; Ziqi Xu; Giang T Vu; Danqing Zhou; Natalie A Chan; Vipat Kuruchittham; Roger S McIntyre; Cyrus S H Ho; Roger Ho; Samuel F Sears
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

5.  Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients.

Authors:  Xiangyu Kong; Fanyang Kong; Kailian Zheng; Min Tang; Yi Chen; Jiahuan Zhou; Yi Li; Le Diao; Shouxin Wu; Piqi Jiao; Tong Su; Yuchao Dong
Journal:  Front Psychiatry       Date:  2020-11-20       Impact factor: 4.157

Review 6.  Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis.

Authors:  Felicia Ceban; Susan Ling; Leanna M W Lui; Yena Lee; Hartej Gill; Kayla M Teopiz; Nelson B Rodrigues; Mehala Subramaniapillai; Joshua D Di Vincenzo; Bing Cao; Kangguang Lin; Rodrigo B Mansur; Roger C Ho; Joshua D Rosenblat; Kamilla W Miskowiak; Maj Vinberg; Vladimir Maletic; Roger S McIntyre
Journal:  Brain Behav Immun       Date:  2021-12-29       Impact factor: 7.217

Review 7.  Onset and frequency of depression in post-COVID-19 syndrome: A systematic review.

Authors:  Olivier Renaud-Charest; Leanna M W Lui; Sherry Eskander; Felicia Ceban; Roger Ho; Joshua D Di Vincenzo; Joshua D Rosenblat; Yena Lee; Mehala Subramaniapillai; Roger S McIntyre
Journal:  J Psychiatr Res       Date:  2021-09-30       Impact factor: 5.250

8.  Stress, Anxiety, and Depression for Chinese Residents in Japan during the COVID-19 Pandemic.

Authors:  Qin Hu; Maki Umeda
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

Review 9.  Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review.

Authors:  Guoli Wei; Jialin Gu; Zhancheng Gu; Cheng Du; Xiaofei Huang; Haiyan Xing; Lingchang Li; Aiping Zhang; Xingxing Hu; Jiege Huo
Journal:  Front Neurol       Date:  2022-01-18       Impact factor: 4.003

10.  The impact of the COVID-19 pandemic on physical and mental health in the two largest economies in the world: a comparison between the United States and China.

Authors:  Cuiyan Wang; Connor Tripp; Samuel F Sears; Linkang Xu; Yilin Tan; Danqing Zhou; Wenfang Ma; Ziqi Xu; Natalie A Chan; Cyrus Ho; Roger Ho
Journal:  J Behav Med       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.